|
December 21 2000
Lek's Presents for more than 1,100 Children in 14 Health Care Institutions and Foster Homes
December 07 2000
January Shareholders Meeting
November 13 2000
Lek Introduces New Form of Cold Medicine - Pleasant and Effective Relief from Cold and Flu Symptoms
October 28 2000
Lek Pharmaceutical appoints Financial Advisor
October 09 2000
Lek and Lendava Municipality are building a Waste Water Treatment Plant
October 05 2000
Lek in Co-operation with the Slovene Medical Web Portal Jupsline enables access to Professional Information
September 25 2000
The new Development Centre - One of Lek's Present Key Investments
September 11 2000
US ambassador on a visit to Lek Lendava
August 29 2000
Half-Year Sales Results exceeded the Plan
August 23 2000
Lek enters the US market with enalapril
July 26 2000
Jo¾e Obersnel - the new President of Lek Supervisory Board
July 19 2000
Minister of Health on an official visit to Lek
July 04 2000
Shareholders supported the majority of proposals given at the General Meeting of Lek d.d.
June 21 2000
Lek files documentation for the acquisition of the marketing authorization for the drug omeprazol in the USA
June 20 2000
Lek opens a new representative office in Riga, Latvia
June 14 2000
In the first quarter Lek exceeded its objectives
May 15 2000
Lek's business centre for South-Eastern Europe just opened
May 11 2000
Lek's comeback to the American market
March 21 2000
Japanese dispute settled
March 08 2000
A donation for humanitarian purposes on the international Women's Day
March 02 2000
Lek reports SIT 3.12 billion of net profit in 1999
January 28 2000
Appointment of a new member to Lek Board of Management
January 19 2000
Sanofi-Synthélabo - Lek d.o.o. joint venture starts to operate
January 14 2000
In 1999 Lek achieved sales objectives set
 |
